- Email: [email protected]
QS86. The Role of the Stomach in Restrictive Procedures for Morbid Obesity
286
ASSOCIATION FOR ACADEMIC SURGERY AND SOCIETY OF UNIVERSITY SURGEONS—ABSTRACTS
GASTROINTESTINAL AND NUTRITION 4: FOREGUT
THE MANAGEMENT OF THORACIC ESOPHAGEAL CANCER. T. Nakamura, T. Imanishi, S. Tahara, D. Kuroda, Y. Kuroda; Kobe University, Graduate School of Medicine, Kobe, Japan
QS81. DEVELOPING A NATURAL ORIFICE TRANSLUMINAL ENDOSCOPIC SURGERY (NOTES®) ROUX-EN-Y GASTRIC BYPASS TECHNIQUE. A. K. Madan1, E. Lo Menzo1, J. M. Martinez1, C. Y. Ro1, A. Iglesias1, K. A. Khan2, D. S. Tichansky2; 1 University of Miami Miller School of Medicine, Miami, FL; 2University of Tennessee Health Science Center, Memphis, TN
QS93. MODULATION OF HEAT SHOCK PROTEIN EXPRESSION IN HUMAN GASTRIC EPITHELIUM: EFFECT OF OXYGEN FREE RADICAL INDUCED APOPTOSIS. A. M. Leung, M. J. Redlak, T. A. Miller; Virginia Commonwealth University, Medical College of Virginia, Richmond, VA
QS82. ANNUAL LINEAR PTH INCREASE MORE SIGNIFICANT IN WOMEN AFTER GASTRIC BYPASS. J. B. Bowen, K. L. Haines, S. F. Gallagher; University of South Florida College of Medicine, Tampa, FL
QS94. A PROPENSITY-SCORE ANALYSIS OF COLONIC AND GASTRIC CONDUIT FOR ESOPHAGEAL RECONSTRUCTION FOLLOWING ESOPHAGOGASTRECTOMY FOR CANCER. K. T. Sawicki, J. S. Lee, L. K. Perigo, M. B. Orringer, A. C. Chang; University of Michigan, Ann Arbor, MI
QS83. SLEEVE GASTRECTOMY WITH VICRYL MESH IMPROVES EXCESS WEIGHT LOSS. E. E. Frezza1, C. Witt2, C. Wei2, M. S. Wachtel2; 1University of Alabama at Birmingham, Birmingham, AL; 2Texas Tech University Health Sciences Center, Lubbock, TX
QS95. RANDOMIZED TRIALS EVALUATING THE PHYSIOLOGIC IMPACT OF NOTES. J. Bingener, E. Moran, C. Gostout; Mayo Clinic Rochester, Rochester, MN
QS84. PERIOPERATIVE DIFFERENCES BETWEEN THE LAP-BAND® AND REALIZE™ BANDS: INITIAL EXPERIENCE. P. H. Nguyen, D. Stefanidis, T. S. Kuwada, A. S. Prabhu, Y. Y. Yurko, A. E. Lincourt, B. Heniford, K. S. Gersin; Carolinas Medical Center, Charlotte, NC QS85. RECENT TRENDS IN BARIATRIC SURGERY CASE VOLUME. G. P. Kohn, J. A. Galanko, D. W. Overby, T. M. Farrell; University of North Carolina, Chapel Hill, NC QS86. THE ROLE OF THE STOMACH IN RESTRICTIVE PROCEDURES FOR MORBID OBESITY. E. E. Frezza1, S. E. Wozniak2, L. Gee2, A. Moreland2, M. S. Wachtel2; 1University of Alabama at Birmingham, Birmingham, AL; 2Texas Tech University Health Sciences Center, Lubbock, AL QS87. THE INCIDENCE OF VITAMIN A DEFICIENCY AND OCULAR SYMPTOMS AFTER ROUX-EN Y GASTRIC BYPASS. M. J. Eckert, J. T. Perry, V. Y. Sohn, D. S. Cuadrado, J. H. Boden, M. J. Martin, R. M. Rush, S. R. Steele; Madigan Army Medical Center, Tacoma, WA QS88. INDICATOR OF CERVICAL LYMPH NODE METASTASIS IN THORATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA: CONSECUTIVE 100 PATIENTS. Y. Imamura, N. Hayashi, N. Satoh, R. Karashima, Y. Hiyoshi, Y. Nagai, N. Yoshida, E. Toyama, M. Watanabe, H. Badeo; Kumamoto University, Kumamoto city, Japan
QS96. LAPAROSCOPIC RESECTION OF GASTROINTESTINAL STROMAL TUMORS (GIST). T. Anene-Maidoh, K. A. Chojnacki, B. Profeta, F. E. Rosato, Jr., E. L. Rosato, A. C. Berger; Thomas Jefferson University, Philadelphia, PA QS97. DOES CIRCULAR STAPLED ESOPHAGOGASTRIC ANASTOMOTIC SIZE OR LEAK AFFECT THE INCIDENCE OF POST OPERATIVE STRICTURES? L. A. Gutierrez1, S. S. Yendamuri2, T. L. Demmy2, H. R. Nava2, T. Mashtare1, N. I. Khushalani2, G. Y. Yang2, C. E. Nwogu2; 1SUNY Buffalo, Buffalo, NY; 2 Roswell Park Cancer Institute, Buffalo, NY QS98. THE IMPORTANCE OF INTEGRATED MULTIMODALITY THERAPIES IN THE TREATMENT OF GASTRIC ADENOCARCINOMA. M. C. Cheung, D. Franceschi, M. Scarlata, L. G. Koniaris; University of Miami, Miami, FL QS99. ANASTOMOTIC COMPLICATIONS ASSOCIATED WITH STAPLED VERSUS HAND-SEWN CERVICAL ESOPHAGO-GASTRIC ANASTOMOSIS. S. G. Worrell, S. K. Mittal, S. Mumtaz, T. Kazuto; Creighton University, Omaha, NE QS100. DOES ABDOMINAL WALL CLOSURE WITH PROPHYLACTIC BIOPROSTHETIC MATERIAL PROTECT AGAINST THE DEVELOPMENT OF INCISIONAL HERNIA IN HIGH RISK PATIENTS? O. H. Llaguna, D. V. Avgerinos, P. Nagda, D. Elfant, E. C. Goodman, I. Leitman; Albert Einstein College of Medicine-Beth Israel Medical Center, New York, NY
ONCOLOGY 9: BREAST-CLINICAL QS89. --------------WITHDRAWN------------QS90. CALCIUM-SENSING RECEPTOR: A POTENTIAL OFFSWITCH FOR GASTRIC ACID SECRETION. E. Arena1, U. Hellmich2, A. Schilcher2, J. P. Geibel1; 1Yale University, New Haven, CT; 2 Paracelsus University, Salzburg, Austria QS91. LAPAROSCOPIC ANTRECTOMY FOR THE TREATMENT OF TYPE I GASTRIC CARCINOID TUMORS. J. OzaoChoy, K. Buch, J. A. Strauchen, R. P. Warner, C. M. Divino; Mount Sinai School of Medicine, New York, NY QS92. IMPACT OF VASCULAR ANASTOMOSIS TO THE GASTRIC TUBES AND THORACOSCOPIC ESOPHAGECTOMY IN
QS101. RISING RATES OF CONTRALATERAL PROPHYLACTIC MASTECTOMY AMONG PATIENTS WITH DUCTAL CARCINOMA IN SITU. T. Tuttle, S. Jarosek, E. Habermann, A. Arrington, A. Abraham, T. Morris, B. Virnig; University of Minnesota, Minneapolis, MN QS102. TLE3-A CANDIDATE BIOMARKER OF TAXANE RESPONSE IN BREAST CANCER. S. A. Kulkarni1, D. G. Hicks2, N. Watroba1, C. Murekesyisoni1, R. Beck3, B. Z. Ring3, N. Estopinal4, M. T. Schreeder4, R. S. Seitz3, D. Ross3; 1Roswell Park Cancer Institute/SUNY Buffalo, Buffalo, NY; 2University of Rochester, Rochester, NY; 3Applied Genomics, Inc., Burlingame, CA; 4Clearview Cancer Institute, Huntsville, AL
ASSOCIATION FOR ACADEMIC SURGERY AND SOCIETY OF UNIVERSITY SURGEONS—ABSTRACTS
GASTROINTESTINAL AND NUTRITION 4: FOREGUT
THE MANAGEMENT OF THORACIC ESOPHAGEAL CANCER. T. Nakamura, T. Imanishi, S. Tahara, D. Kuroda, Y. Kuroda; Kobe University, Graduate School of Medicine, Kobe, Japan
QS81. DEVELOPING A NATURAL ORIFICE TRANSLUMINAL ENDOSCOPIC SURGERY (NOTES®) ROUX-EN-Y GASTRIC BYPASS TECHNIQUE. A. K. Madan1, E. Lo Menzo1, J. M. Martinez1, C. Y. Ro1, A. Iglesias1, K. A. Khan2, D. S. Tichansky2; 1 University of Miami Miller School of Medicine, Miami, FL; 2University of Tennessee Health Science Center, Memphis, TN
QS93. MODULATION OF HEAT SHOCK PROTEIN EXPRESSION IN HUMAN GASTRIC EPITHELIUM: EFFECT OF OXYGEN FREE RADICAL INDUCED APOPTOSIS. A. M. Leung, M. J. Redlak, T. A. Miller; Virginia Commonwealth University, Medical College of Virginia, Richmond, VA
QS82. ANNUAL LINEAR PTH INCREASE MORE SIGNIFICANT IN WOMEN AFTER GASTRIC BYPASS. J. B. Bowen, K. L. Haines, S. F. Gallagher; University of South Florida College of Medicine, Tampa, FL
QS94. A PROPENSITY-SCORE ANALYSIS OF COLONIC AND GASTRIC CONDUIT FOR ESOPHAGEAL RECONSTRUCTION FOLLOWING ESOPHAGOGASTRECTOMY FOR CANCER. K. T. Sawicki, J. S. Lee, L. K. Perigo, M. B. Orringer, A. C. Chang; University of Michigan, Ann Arbor, MI
QS83. SLEEVE GASTRECTOMY WITH VICRYL MESH IMPROVES EXCESS WEIGHT LOSS. E. E. Frezza1, C. Witt2, C. Wei2, M. S. Wachtel2; 1University of Alabama at Birmingham, Birmingham, AL; 2Texas Tech University Health Sciences Center, Lubbock, TX
QS95. RANDOMIZED TRIALS EVALUATING THE PHYSIOLOGIC IMPACT OF NOTES. J. Bingener, E. Moran, C. Gostout; Mayo Clinic Rochester, Rochester, MN
QS84. PERIOPERATIVE DIFFERENCES BETWEEN THE LAP-BAND® AND REALIZE™ BANDS: INITIAL EXPERIENCE. P. H. Nguyen, D. Stefanidis, T. S. Kuwada, A. S. Prabhu, Y. Y. Yurko, A. E. Lincourt, B. Heniford, K. S. Gersin; Carolinas Medical Center, Charlotte, NC QS85. RECENT TRENDS IN BARIATRIC SURGERY CASE VOLUME. G. P. Kohn, J. A. Galanko, D. W. Overby, T. M. Farrell; University of North Carolina, Chapel Hill, NC QS86. THE ROLE OF THE STOMACH IN RESTRICTIVE PROCEDURES FOR MORBID OBESITY. E. E. Frezza1, S. E. Wozniak2, L. Gee2, A. Moreland2, M. S. Wachtel2; 1University of Alabama at Birmingham, Birmingham, AL; 2Texas Tech University Health Sciences Center, Lubbock, AL QS87. THE INCIDENCE OF VITAMIN A DEFICIENCY AND OCULAR SYMPTOMS AFTER ROUX-EN Y GASTRIC BYPASS. M. J. Eckert, J. T. Perry, V. Y. Sohn, D. S. Cuadrado, J. H. Boden, M. J. Martin, R. M. Rush, S. R. Steele; Madigan Army Medical Center, Tacoma, WA QS88. INDICATOR OF CERVICAL LYMPH NODE METASTASIS IN THORATIC ESOPHAGEAL SQUAMOUS CELL CARCINOMA: CONSECUTIVE 100 PATIENTS. Y. Imamura, N. Hayashi, N. Satoh, R. Karashima, Y. Hiyoshi, Y. Nagai, N. Yoshida, E. Toyama, M. Watanabe, H. Badeo; Kumamoto University, Kumamoto city, Japan
QS96. LAPAROSCOPIC RESECTION OF GASTROINTESTINAL STROMAL TUMORS (GIST). T. Anene-Maidoh, K. A. Chojnacki, B. Profeta, F. E. Rosato, Jr., E. L. Rosato, A. C. Berger; Thomas Jefferson University, Philadelphia, PA QS97. DOES CIRCULAR STAPLED ESOPHAGOGASTRIC ANASTOMOTIC SIZE OR LEAK AFFECT THE INCIDENCE OF POST OPERATIVE STRICTURES? L. A. Gutierrez1, S. S. Yendamuri2, T. L. Demmy2, H. R. Nava2, T. Mashtare1, N. I. Khushalani2, G. Y. Yang2, C. E. Nwogu2; 1SUNY Buffalo, Buffalo, NY; 2 Roswell Park Cancer Institute, Buffalo, NY QS98. THE IMPORTANCE OF INTEGRATED MULTIMODALITY THERAPIES IN THE TREATMENT OF GASTRIC ADENOCARCINOMA. M. C. Cheung, D. Franceschi, M. Scarlata, L. G. Koniaris; University of Miami, Miami, FL QS99. ANASTOMOTIC COMPLICATIONS ASSOCIATED WITH STAPLED VERSUS HAND-SEWN CERVICAL ESOPHAGO-GASTRIC ANASTOMOSIS. S. G. Worrell, S. K. Mittal, S. Mumtaz, T. Kazuto; Creighton University, Omaha, NE QS100. DOES ABDOMINAL WALL CLOSURE WITH PROPHYLACTIC BIOPROSTHETIC MATERIAL PROTECT AGAINST THE DEVELOPMENT OF INCISIONAL HERNIA IN HIGH RISK PATIENTS? O. H. Llaguna, D. V. Avgerinos, P. Nagda, D. Elfant, E. C. Goodman, I. Leitman; Albert Einstein College of Medicine-Beth Israel Medical Center, New York, NY
ONCOLOGY 9: BREAST-CLINICAL QS89. --------------WITHDRAWN------------QS90. CALCIUM-SENSING RECEPTOR: A POTENTIAL OFFSWITCH FOR GASTRIC ACID SECRETION. E. Arena1, U. Hellmich2, A. Schilcher2, J. P. Geibel1; 1Yale University, New Haven, CT; 2 Paracelsus University, Salzburg, Austria QS91. LAPAROSCOPIC ANTRECTOMY FOR THE TREATMENT OF TYPE I GASTRIC CARCINOID TUMORS. J. OzaoChoy, K. Buch, J. A. Strauchen, R. P. Warner, C. M. Divino; Mount Sinai School of Medicine, New York, NY QS92. IMPACT OF VASCULAR ANASTOMOSIS TO THE GASTRIC TUBES AND THORACOSCOPIC ESOPHAGECTOMY IN
QS101. RISING RATES OF CONTRALATERAL PROPHYLACTIC MASTECTOMY AMONG PATIENTS WITH DUCTAL CARCINOMA IN SITU. T. Tuttle, S. Jarosek, E. Habermann, A. Arrington, A. Abraham, T. Morris, B. Virnig; University of Minnesota, Minneapolis, MN QS102. TLE3-A CANDIDATE BIOMARKER OF TAXANE RESPONSE IN BREAST CANCER. S. A. Kulkarni1, D. G. Hicks2, N. Watroba1, C. Murekesyisoni1, R. Beck3, B. Z. Ring3, N. Estopinal4, M. T. Schreeder4, R. S. Seitz3, D. Ross3; 1Roswell Park Cancer Institute/SUNY Buffalo, Buffalo, NY; 2University of Rochester, Rochester, NY; 3Applied Genomics, Inc., Burlingame, CA; 4Clearview Cancer Institute, Huntsville, AL